Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
GE HealthCare Technologies Inc. (GEHC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/07/2025: GEHC (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit 14.47% | Avg. Invested days 45 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 04/07/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 27.67B USD | Price to earnings Ratio 13.94 | 1Y Target Price 100.51 |
Price to earnings Ratio 13.94 | 1Y Target Price 100.51 | ||
Volume (30-day avg) 4293987 | Beta 1.31 | 52 Weeks Range 58.04 - 94.80 | Updated Date 04/6/2025 |
52 Weeks Range 58.04 - 94.80 | Updated Date 04/6/2025 | ||
Dividends yield (FY) 0.23% | Basic EPS (TTM) 4.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 10.13% | Operating Margin (TTM) 16.66% |
Management Effectiveness
Return on Assets (TTM) 5.77% | Return on Equity (TTM) 25.69% |
Valuation
Trailing PE 13.94 | Forward PE 12.85 | Enterprise Value 34168547755 | Price to Sales(TTM) 1.41 |
Enterprise Value 34168547755 | Price to Sales(TTM) 1.41 | ||
Enterprise Value to Revenue 1.74 | Enterprise Value to EBITDA 9.32 | Shares Outstanding 457297984 | Shares Floating 456109334 |
Shares Outstanding 457297984 | Shares Floating 456109334 | ||
Percent Insiders 0.2 | Percent Institutions 88.35 |
Analyst Ratings
Rating 4.15 | Target Price 96.76 | Buy 3 | Strong Buy 11 |
Buy 3 | Strong Buy 11 | ||
Hold 5 | Sell - | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
GE HealthCare Technologies Inc.
Company Overview
History and Background
GE HealthCare Technologies Inc. was founded in 2023 as a spin-off from General Electric. It builds on GE's long history in medical technology and healthcare solutions. It aims to focus on innovation in precision health.
Core Business Areas
- Imaging: Provides a wide array of medical imaging technologies, including MRI, CT, X-ray, PET, and nuclear medicine systems.
- Ultrasound: Offers a comprehensive range of ultrasound systems for various clinical applications, including radiology, cardiology, and women's health.
- Patient Care Solutions: Delivers solutions for patient monitoring, anesthesia delivery, and respiratory care in acute care settings.
- Pharmaceutical Diagnostics: Develops and manufactures contrast media and radiopharmaceuticals used in medical imaging procedures.
Leadership and Structure
Peter Arduini serves as the President and CEO. The company operates with a business unit structure, focusing on key modalities and solutions.
Top Products and Market Share
Key Offerings
- MRI Systems: GE HealthCare is a major player in the MRI market, offering a range of systems from 1.5T to 7T. Competitors include Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. Estimates suggest they hold a significant share of the global MRI market, generating substantial revenue.
- CT Scanners: GE HealthCare's CT scanners are widely used for diagnostic imaging. Competitors include Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. GE Healthcare claims to have the top share in the U.S. CT market with over 36% in the $7.5B global market.
- Ultrasound Systems: GE HealthCare provides ultrasound systems for various applications, including general imaging, womenu2019s health, and cardiovascular. Competitors include Philips Healthcare and Siemens Healthineers. Revenue generation is significant given broad adoption rates.
- Contrast Media: GE HealthCare develops and manufactures contrast agents used to enhance medical imaging. Competitors include Bayer and Bracco Imaging.
Market Dynamics
Industry Overview
The medical technology industry is driven by aging populations, increasing prevalence of chronic diseases, technological advancements, and growing demand for personalized medicine.
Positioning
GE HealthCare is positioned as a leading provider of medical imaging and patient care technologies, focusing on innovation, digital solutions, and precision health.
Total Addressable Market (TAM)
The global medical device market is valued at hundreds of billions of dollars. GE HealthCare is positioned to capture a significant portion of this TAM through its diverse product portfolio and global presence.
Upturn SWOT Analysis
Strengths
- Strong Brand Recognition
- Extensive Product Portfolio
- Global Presence
- Technological Innovation
- Established Customer Base
Weaknesses
- High Debt Levels (Related to Spin-off)
- Complexity of Product Portfolio
- Integration Challenges (with acquisitions)
- Competition from Specialized Players
Opportunities
- Expansion into Emerging Markets
- Development of Digital Health Solutions
- Strategic Partnerships and Acquisitions
- Growth in Personalized Medicine
- Increased Demand for Diagnostic Imaging
Threats
- Intense Competition
- Regulatory Changes
- Economic Downturns
- Technological Obsolescence
- Supply Chain Disruptions
Competitors and Market Share
Key Competitors
- SIEMENS HEALTHINEERS(no US Stock Symbol)
- PHG
- CAJ
Competitive Landscape
GE HealthCare benefits from its established brand and broad product portfolio, but faces competition from specialized players and larger diversified companies. Competition is intense.
Major Acquisitions
Caption Health
- Year: 2023
- Acquisition Price (USD millions): 100
- Strategic Rationale: Acquisition to expand ultrasound capabilities through AI technologies.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is dependent upon public records. Check with available resources.
Future Projections: Future projections from analysts depend on analyst reports. Check with available resources.
Recent Initiatives: Recent initiatives are in driving growth through digital technologies.
Summary
GE HealthCare, a spin-off from GE, is a major player in medical imaging and patient care technologies with a broad global reach. While its strong brand and innovative portfolio are strengths, it faces competitive pressures and integration challenges. Opportunities exist in emerging markets and digital health solutions. Its success hinges on navigating intense competition and managing its debt effectively.
Similar Companies
MDT
Medtronic PLC
MDT
Medtronic PLC
PHG
Koninklijke Philips NV ADR
PHG
Koninklijke Philips NV ADR
VEEV
Veeva Systems Inc Class A
VEEV
Veeva Systems Inc Class A
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Financial News Sources
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market conditions and company performance can change rapidly. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About GE HealthCare Technologies Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2023-01-04 | President, CEO & Director Mr. Peter J. Arduini | ||
Sector Healthcare | Industry Health Information Services | Full time employees 53000 | Website https://www.gehealthcare.com |
Full time employees 53000 | Website https://www.gehealthcare.com | ||
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.